EHC/LinkedIn
Feb 15, 2026, 10:52
Awareness and Research on Factor V Deficiency Are Critical – EHC
European Haemophilia Consortium (EHC) shared a post on LinkedIn:
“Extremely Rare Bleeding Disorder of the Month: Factor V Deficiency
Nosebleeds that won’t stop. Bruises from nowhere.
Bleeding that just keeps going.
For people with this rare clotting disorder, these aren’t occasional issues—they’re part of life.
The condition can affect anyone at any age, but knowing the signs matters.
Right now, treatment options are limited, which is why awareness and research are so critical.
Want to learn more?
On the ERIN Focus Area page on our EHC Community website, you can find relevant webinars, podcasts, and publications.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026